ZEPOSIA
associated with 2 other trademarks
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple scler...

Words that describe this trademark:

blood disease cancer  autoimmune disease blood  pharmaceutical preparations  disease blood  inflammatory disease  treatment leukemia  disease autoimmune  auto inflammatory  preparations  leukemia 

Serial Number:

86959853

Mark:

ZEPOSIA

Status:

Section 8 and 15-accepted and acknowledged

Status Date:

07-19-2023

Filing Date:

Registration Number:

5135866

Registration Date:

02-07-2017

Goods and Services:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-22-2016

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company